Skip to main content

General Dermatology

General Dermatology

Featured

Derm Q&A
A recent study showed several inflammatory skin diseases, including atopic dermatitis, were associated with an increased risk for venous thromboembolism. In an interview with The Dermatologist, Jonathan Silverberg, MD, PhD, MPH, discussed these findings and their implications for clinical practice.
FDA Alerts
The FDA announced that ligelizumab has received the Breakthrough Therapy designation for the treatment of chronic spontaneous urticaria for patients who have had an inadequate response to H1-antihista
News
Previous studies have inconclusive findings regarding the association of bullous pemphigoid and solid malignancies. A recent study published in The Journal of Dermatology found that patients with bull
News
Combination treatment with a home-based handheld narrowband UV-B (NB-UVB) and a topical corticosteroid (TCS) may be a more effective option for treatment of localized vitiligo than TCS alone. The resu
Back to Top